Search

Author/Creator Herrmann, Richard

2. First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13). (June 2018)

Authors:
Wicki, Andreas; Brown, Nicholas; Xyrafas, Alexandros; Bize, Vincent; Hawle, Hanne; Berardi, Simona; Cmiljanović, Nataša; Cmiljanović, Vladimir; Stumm, Michael; Dimitrijević, Saša; Herrmann, Richard; Prêtre, Vincent; Ritschard, Reto; Tzankov, Alexandar; Hess, Viviane; Childs, Alexa; Hierro, Cinta;...
Journal:
European journal of cancer
Issue:
Volume 96(2018)
Page Start:
6
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores. (January 2019)

Authors:
Gargiulo, Piera; Dietrich, Daniel; Herrmann, Richard; Bodoky, György; Ruhstaller, Thomas; Scheithauer, Werner; Glimelius, Bengt; Berardi, Simona; Pignata, Sandro; Brauchli, Peter
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 11(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease. Issue 3 (March 2018)

Authors:
ter Veer, Emil; van Rijssen, L Bengt; Besselink, Marc G; Mali, Rosa M A; Berlin, Jordan D; Boeck, Stefan; Bonnetain, Franck; Chau, Ian; Conroy, Thierry; Van Cutsem, Eric; Deplanque, Gael; Friess, Helmut; Glimelius, Bengt; Goldstein, David; Herrmann, Richard; Labianca, Roberto; Van Laethem, Jean-L...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 3(2018)
Page Start:
e151
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗